Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

This study has suspended participant recruitment.
Sponsor:
Information provided by (Responsible Party):
Galapagos NV
ClinicalTrials.gov Identifier:
NCT01039103
First received: December 20, 2009
Last updated: October 24, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: September 2012
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)